Literature DB >> 18573433

Surgery remains the most effective treatment for Paget-Schroetter syndrome: 50 years' experience.

Harold C Urschel1, Amit N Patel.   

Abstract

BACKGROUND: Significant improvements were made in the diagnosis and management of Paget-Schroetter syndrome (thrombosis of the axillary-subclavian vein) secondary to thoracic outlet syndrome during the past 50 years. The diagnosis has often been extremely difficult.
METHODS: Multiple approaches both in diagnosis and therapy have been tried during the years. After recognizing that the underlying pathologic process resulted from an abnormal insertion of the costoclavicular ligament laterally on the first rib, along with hypertrophy of the scalenus anticus muscle, 506 of 626 extremities have been managed by thrombolytic therapy followed by prompt transaxillary resection of the first rib. These patients have been followed up from 1 to 32 years (average of 7.2 years +/- 1.0 standard deviation).
RESULTS: Four hundred eighty-six patients (96%) improved. Because the pathophysiology is not well understood, many venograms suggest intraluminal disease rather than external compression. Therefore, attempts at opening the narrowed vein with intraarterial techniques do not work. Use of percutaneous venous angioplasty with stents have all occluded in our experience, making further management difficult. Venous bypass grafts fail because of low venous pressure.
CONCLUSIONS: Recognition that an abnormal congenital lateral insertion of the costoclavicular ligament on the first rib causes venous occlusion in Paget-Schroetter syndrome has led to acute thrombolysis, followed by prompt first rib resection, as the ideal management.

Entities:  

Mesh:

Year:  2008        PMID: 18573433     DOI: 10.1016/j.athoracsur.2008.03.021

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  32 in total

1.  Upper Extremity Deep Vein Thrombosis: The Oft-forgotten Cousin of Venous Thromboembolic Disease.

Authors:  Ronan Margey; Robert M Schainfeld
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-04

2.  Subclavian vein thrombosis in an otherwise healthy 9-year-old boy.

Authors:  Katie Young; Oliver Tunstall; Andrew Mumford
Journal:  BMJ Case Rep       Date:  2014-05-22

3.  Thoracic outlet syndrome: a controversial clinical condition. Part 2: non-surgical and surgical management.

Authors:  Troy L Hooper; Jeff Denton; Michael K McGalliard; Jean-Michel Brismée; Phillip S Sizer
Journal:  J Man Manip Ther       Date:  2010-09

4.  Spontaneous deep vein thrombosis in the upper extremity of a 45-year-old woman.

Authors:  Corey M Stein; Anne McLeod; Luke A Devine
Journal:  CMAJ       Date:  2014-11-03       Impact factor: 8.262

Review 5.  Minimally invasive treatments for venous compression syndromes.

Authors:  Paul C Hulsberg; Eric McLoney; Sasan Partovi; Jon C Davidson; Indravadan J Patel
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

Review 6.  Venous Compression Syndromes: a Review.

Authors:  Sunil Iyer; John F Angle; Andre Uflacker; Aditya M Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

Review 7.  Advanced Stent Graft Treatment of Venous Stenosis Affecting Hemodialysis Vascular Access: Case Illustrations.

Authors:  Darshan Patel; Charles E Ray; R Peter Lokken; James T Bui; Andrew J Lipnik; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

8.  [Rare combination of causes in thoracic inlet syndrome].

Authors:  I Porokhovnikov; S Venth; T Kroeßner; A Kebsch; T Lesser
Journal:  Chirurg       Date:  2017-05       Impact factor: 0.955

Review 9.  Paget-Schroetter syndrome: treatment of venous thrombosis and outcomes.

Authors:  Patrick Hangge; Lisa Rotellini-Coltvet; Amy R Deipolyi; Hassan Albadawi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

10.  Paget-Schroetter syndrome with bilateral pulmonary emboli.

Authors:  Garrison Glavich; Jeffrey Gourley; Victor Fong
Journal:  Radiol Case Rep       Date:  2017-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.